Physician profile
Mark A Vila
NPI 1073948592
$4,844.76
in general payments reported to CMS, 2019-2025
23 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2021: $911 · 2022: $620 · 2023: $862 · 2024: $543 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,009.65 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Olympus Corporation of The Americas | $731.36 | 2019 | |
| Insmed, INC. | $502.38 | 2019-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $339.17 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $301.90 | 2019-2023 | |
| Ethicon INC. | $298.62 | 2019-2022 | |
| Mylan Specialty L.P. | $187.83 | 2019-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.83 | 2019-2021 | |
| Abbott Laboratories | $156.29 | 2025 | 2nd Gen Centrimag Primary Console |
| Genentech, INC. | $145.14 | 2023 | |
| Grifols USA, LLC | $126.26 | 2019 | |
| Genentech USA, INC. | $122.14 | 2019 | |
| Pulmonx Corporation | $121.43 | 2021 | |
| Inspire Medical Systems, INC. | $117.84 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $107.62 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $105.98 | 2024 | Impella |
| Getinge USA Sales, LLC | $85.55 | 2019 | |
| United Therapeutics Corporation | $81.48 | 2023 | |
| Haemonetics Corporation | $37.88 | 2022-2025 | Teg6s Hemostasis System |
| Edwards Lifesciences Corporation | $31.23 | 2021 | |
| Philips North America LLC | $21.65 | 2019 | |
| Abbvie INC. | $19.48 | 2025 | |
| Medtronic, INC. | $19.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Vila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.